Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enhanced thrombospondin-1 causes dysfunction of vascular endothelial cells derived from Fabry disease-induced pluripotent stem cells
Hyo‐Sang Do, Sang-Wook Park, Ilkyun Im, et al.
EBioMedicine (2020) Vol. 52, pp. 102633-102633
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Kidney Decellularized Extracellular Matrix Enhanced the Vascularization and Maturation of Human Kidney Organoids
Jin Won Kim, Sun Ah Nam, Jawoon Yi, et al.
Advanced Science (2022) Vol. 9, Iss. 15
Open Access | Times Cited: 116
Pathogenesis and Molecular Mechanisms of Anderson–Fabry Disease and Possible New Molecular Addressed Therapeutic Strategies
Antonino Tuttolomondo, Irene Simonetta, Renata Riolo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10088-10088
Open Access | Times Cited: 50
Pathology and pathogenic pathways in fabry nephropathy
Sandro Feriozzi, Paula Rozenfeld
Clinical and Experimental Nephrology (2021) Vol. 25, Iss. 9, pp. 925-934
Closed Access | Times Cited: 30
CRISPR/Cas9-mediated A4GALT suppression rescues Fabry disease phenotypes in a kidney organoid model
Sheng Cui, Yoo Jin Shin, Xianying Fang, et al.
Translational research (2023) Vol. 258, pp. 35-46
Closed Access | Times Cited: 13
Regulation of self-renewal in ovarian cancer stem cells by fructose via chaperone-mediated autophagy
Eun Jung Sohn, Jae Ho Kim, Sec-Ok Oh, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 6, pp. 166723-166723
Open Access | Times Cited: 12
Data-independent LC-MS/MS analysis of ME/CFS plasma reveals a dysregulated coagulation system, endothelial dysfunction, downregulation of complement machinery
Massimo Nunes, Maré Vlok, Amy D. Proal, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Human in vitro models for Fabry disease: new paths for unravelling disease mechanisms and therapies
Carla Borisch, Thomas Thum, Christian Bär, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Biomarkers in Fabry Disease. Implications for Clinical Diagnosis and Follow-up
Clara Carnicer-Cáceres, Jose Antonio Arranz-Amo, Cristina Cea-Arestin, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1664-1664
Open Access | Times Cited: 25
Spatially Resolved Transcriptomes of Mammalian Kidneys Illustrate the Molecular Complexity and Interactions of Functional Nephron Segments
Arti M. Raghubar, Duy Pham, Xiao Tan, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 18
Therapeutic effects of lomerizine on vasculopathy in Fabry disease
Jong Bin Choi, Hyo‐Sang Do, Dong‐Won Seol, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The inflammatory pathogenetic pathways of Fabry nephropathy
Sandro Feriozzi, Paula Rozenfeld
Rare Disease and Orphan Drugs Journal (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 3
CRISPR-Cas9-Mediated Correction of SLC12A3 Gene Mutation Rescues the Gitelman’s Disease Phenotype in a Patient-Derived Kidney Organoid System
Sun Woo Lim, Xianying Fang, Sheng Cui, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3019-3019
Open Access | Times Cited: 7
Induced pluripotent stem cells modulate the Wnt pathway in the bleomycin-induced model of idiopathic pulmonary fibrosis
Paria Bayati, Marjan Taherian, Mansoureh Soleimani, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Inborn errors of metabolism: Lessons from iPSC models
Rubén Escribá, Raquel Ferrer‐Lorente, Ángel Raya
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 4, pp. 1189-1200
Open Access | Times Cited: 15
LRP-1 Matricellular Receptor Involvement in Triple Negative Breast Cancer Tumor Angiogenesis
Océane Campion, Jessica Thevenard Devy, Clotilde Billottet, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1430-1430
Open Access | Times Cited: 15
Fasudil alleviates the vascular endothelial dysfunction and several phenotypes of Fabry disease
Jong Bin Choi, Dong‐Won Seol, Hyo‐Sang Do, et al.
Molecular Therapy (2023) Vol. 31, Iss. 4, pp. 1002-1016
Open Access | Times Cited: 6
Ion channels and pain in Fabry disease
Carina Weissmann, Adriana Albanese, Natalia Estefanía Contreras, et al.
Molecular Pain (2021) Vol. 17
Open Access | Times Cited: 13
Treatment switch in Fabry disease- a matter of dose?
Malte Lenders, Peter Nordbeck, Sima Canaan‐Kühl, et al.
Journal of Medical Genetics (2020) Vol. 58, Iss. 5, pp. 342-350
Closed Access | Times Cited: 14
Cracking the code of the cardiovascular enigma: hPSC-derived endothelial cells unveil the secrets of endothelial dysfunction
Fedir N. Kiskin, Yuan Yang, Hao Yang, et al.
Journal of Molecular and Cellular Cardiology (2024) Vol. 192, pp. 65-78
Closed Access | Times Cited: 1
CRISPR/Cas9-mediated suppression of A4GALT rescues endothelial cell dysfunction in a Fabry disease vasculopathy model derived from human induced pluripotent stem cells
Yoo‐Jin Shin, Seung Yun Chae, Hanbi Lee, et al.
Atherosclerosis (2024) Vol. 397, pp. 118549-118549
Open Access | Times Cited: 1
Endothelial Cell Dysfunction and Hypoxia as Potential Mediators of Pain in Fabry Disease: A Human-Murine Translational Approach
Katharina Klug, Marlene Spitzel, Clara Hans, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15422-15422
Open Access | Times Cited: 3
Generation of GLA-knockout human embryonic stem cell lines to model peripheral neuropathy in Fabry disease
Christine R. Kaneski, John A. Hanover, Ulrike H. Schueler Hoffman
Molecular Genetics and Metabolism Reports (2022) Vol. 33, pp. 100914-100914
Open Access | Times Cited: 5
Characterization of cellular phenotypes in neurons derived from induced pluripotent stem cells of male patients with Fabry disease
Takashi Miyajima, Ryo Saito, Hiroko Yanagisawa, et al.
Journal of Inherited Metabolic Disease (2022) Vol. 46, Iss. 1, pp. 143-152
Closed Access | Times Cited: 4
Generation of a CRISPR/Cas9-corrected-hiPSC line (DDLABi001-A) from Fabry disease (FD)-derived iPSCs having α-galactosidase (GLA) gene mutation (c.803_806del)
Jong Bin Choi, Donghyuk Seo, Hyo‐Sang Do, et al.
Stem Cell Research (2022) Vol. 66, pp. 103001-103001
Open Access | Times Cited: 3
Induced pluripotent stem cell modeling of genetic small vessel disease
Katie Newman, Amerikos Argyriou, Tao Wang
Elsevier eBooks (2020), pp. 131-159
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top